bioRxivNeurosciencePreprint
Downregulating α-synuclein in iPSC-derived dopaminergic neurons mimics electrophysiological phenotype of the A53T mutation
Philipp HornaueriD, Gustavo Prack, Nadia Anastasi, Silvia RonchiiD, Taehoon KimiD, Christian DonneriD, Fiscella Michele, Karsten Michael BorgwardtiD, Verdon TayloriD, Ravi JagasiaiD, Damian RoqueiroiD, Andreas R. HierlemanniD, Manuel S. SchröteriD
Abstract
Parkinsons disease (PD) is a common debilitating neurodegenerative disorder, characterized by a progressive loss of dopaminergic (DA) neurons. Mutations, gene dosage increase, and single nucleotide polymorphisms in the -synuclein-encoding gene SNCA either cause or increase the risk for PD. However, neither the function of -synuclein in health and disease, nor its role throughout development is fully understood. Here, we introduce DeePhys, a new tool that allows for data-driven functional phenotyping of neuronal cell lines by combining electrophysiological features inferred from high-density microelectrode array (HD-MEA) recordings with a robust machine learning workflow. We apply DeePhys to human induced pluripotent stem cell (iPSC)-derived DA neuron-astrocyte co-cultures harboring the prominent SNCA mutation A53T and an isogenic control line. Moreover, we demonstrate how DeePhys can facilitate the assessment of cellular and network-level electrophysiological features to build functional phenotypes and to evaluate potential treatment interventions. We find that electrophysiological features across all scales proved to be highly specific for the A53T phenotype, enabled to predict the genotype and age of individual cultures with high accuracy, and revealed a mutant-like phenotype after downregulation of -synuclein.
- organism: human
- assay: electronic health records
- research focus: cell type annotation
- research focus: benchmarking
- research focus: software / tool
- approach: machine learning (classical)
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gene-corrected Parkinson's disease neurons show the A30P alpha-synuclein point mutation leads to reduced neuronal branching and function
Peter A. Barbuti, Bruno F. R. Santos, … Rejko Krüger·bioRxiv·Nov 5, 2020
- iPSC-derived extracellular vesicles rescue deficits in human and mouse models of Parkinsons disease
Wote Amelo Rike, Utkarsh Tripathi, … Shani Stern·bioRxiv·May 26, 2026
- Mice expressing A53T / A30P mutant alpha-synuclein in dopamine neurons do not display behavioral deficits
C. Keomanivong, J. Schamp, … N. Narayanan·bioRxiv·May 25, 2023
- Reduced synaptic activity and dysregulated extracellular matrix pathways are common phenotypes in midbrain neurons derived from sporadic and mutation-associated Parkinson's disease patients
Shani Stern, Shong Lau, … Fred H. Gage·bioRxiv·Dec 31, 2021
- IPSC-derived midbrain astrocytes from Parkinson's disease patients carrying pathogenic SNCA mutations exhibit alpha-synuclein aggregation, mitochondrial fragmentation and excess calcium release
Peter A. Barbuti, Paul M. A. Antony, … Rejko Krüger·bioRxiv·Apr 27, 2020
- Proteostasis dysregulation in p.A53T-α-Synuclein iPSC-derived astrocytes exacerbates neurodegeneration in a Parkinson's disease model with Lewy-like pathology
Christina Paschou, Olympia Apokotou, … Florentia Papastefanaki·bioRxiv·Nov 6, 2024